Aspen Aerogels Q3 revenue record $60.8M; PyroThin revenue $32.8M up 160% QoQ

ASPEN AEROGELS INC

2023-Q3 EPS reported -$0.65 revenue$154,499,000

Record total revenue of $60.8M, up from $36.7M in Q3 2022.
PyroThin revenue of $32.8M, a 160% sequential increase over Q2 2023.
Gross profit margin of 23%, a 6-percentage point improvement vs. prior quarter.
Net loss improved to $13.1M ($0.19 per share) from $29.6M ($0.75) a year ago.
Adjusted EBITDA loss narrowed to $(7.3)M from $(23.2)M in Q3 2022.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.98

ASPEN AEROGELS INC reported the third quarter of 2023 results: revenue $60.8 million, net income $13.1 million, EPS $0.19.

Period: the third quarter of 2023
Revenue: $60.8 million
Net income: $13.1 million
EPS: $0.19
Result: reported results

Exact text from the filing

Total revenue for the third quarter of 2023 was $60.8 million, compared to $36.7 million in the third quarter of last year. Net loss was $13.1 million, compared to a net loss of $29.6 million in the third quarter of last year. Net loss per share was $0.19, compared to a net loss per share of $0.75 in the third quarter of last year.

View on SEC.gov

44 earnings releases filed in the last 30 days. Browse all earnings releases →

ASPEN AEROGELS INC filing history →

Source: SEC EDGAR

accession 0000950170-23-057500

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.